Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ: EVO )

10.86 UNCHANGED
Streaming Delayed Price Updated: 3:59 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 10.86
Bid (Size) 11.09 (9)
Ask (Size) 11.19 (29)
Prev. Close 10.86
Today's Range 10.86 - 10.86
52wk Range 7.800 - 15.04
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Just - Evotec Biologics Enters Strategic Biosimilars Partnership with Sandoz
Via ACCESSWIRE
Just - Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing
Via ACCESSWIRE

Performance

YTD
+33.25%
+33.25%
1 Month
+16.77%
+16.77%
3 Month
+23.55%
+23.55%
6 Month
+24.26%
+24.26%
1 Year
-21.53%
-21.53%

More News

Read More
Evotec SE Provides Update on Cyber Attack
Via ACCESSWIRE
Cyber Attack on Evotec
Via ACCESSWIRE
Evotec and Bristol Myers Squibb Extend and Expand Strategic Neurodegeneration Partnership
Via ACCESSWIRE
Earnings Preview For Evotec
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
Via Benzinga
Evotec SE Preliminary Fiscal Year 2022 Results: 'Ahead of the Curve' - Very Strong Performance in a Challenging Year
Via ACCESSWIRE
Evotec Receives US$ 6.6 m Grant for Drug Discovery in Tuberculosis
Via ACCESSWIRE
Evotec SE to Announce Preliminary Financial Results for Fiscal Year 2022 on 28 March 2023
Via ACCESSWIRE
Evotec Announces Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
Via ACCESSWIRE
Sernova Corp. (TSX: SVA) Featured in Coverage of the 35th Annual Roth Conference
Via Investor Brand Network
Evotec Receives € 150 m Loan from European Investment Bank
Via ACCESSWIRE
Evotec and Related Sciences Expand Integrated Drug Discovery and Development Partnership
Via ACCESSWIRE
Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer
Via ACCESSWIRE
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies
Via ACCESSWIRE
Evotec Achieves Further Progress in Neuroscience Collaboration with Bristol Myers Squibb
Via ACCESSWIRE
CarGurus, Disney, Upstart And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket
Via Benzinga
Evotec SE Reports Results for the First Nine Months 2022 and Provides Corporate Update
Via ACCESSWIRE
Evotec SE to Announce Results for the First Nine Months 2022 on 09 November 2022
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.